...
首页> 外文期刊>Seminars in Nuclear Medicine >The pathologist's role in sentinel lymph node evaluation.
【24h】

The pathologist's role in sentinel lymph node evaluation.

机译:病理学家在前哨淋巴结评估中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with high-risk (thick, deeply invasive) primary melanoma were, in the past, managed by wide local excision and elective node dissection or wide local excision alone, with subsequent lymphadenectomy if the regional nodes developed clinically detectable metastases. We recently developed a more logical approach called selective lymph node dissection. To be effective, this requires close collaboration of surgeons, pathologists, and nuclear medicine physicians. The draining lymph node basin is identified preoperatively by lymphoscintigraphy. During surgery, a marker dye (isosulfan blue) and radioactive technetium labeled albumin are injected intradermally around the primary melanoma and the afferent lymphatics are followed up to the first lymph nodes of the ipsilateral regional nodal basin. The surgeon excises the blue-colored and maximally radioactive sentinel nodes and the pathologist critically evaluates these for the presence of a metastatic tumor. If the sentinel nodes are tumor free, no further nodal dissection is undertaken; if a tumor is present, a complete dissection of the nodal basin is performed. We have examined 1,119 sentinel lymph nodes from 669 patients treated by selective lymph node dissection. We identified melanoma cells in sentinel nodes from 126 patients (17.8%). A single node contained tumors in 67% of patients, 2 nodes were positive in 25%, and the remaining 12% of patients had three tumor-containing nodes. Melanoma cells were dispersed singly or in variably sized groups, usually in the peripheral nodal sinus. In around 40% of patients, immunohistochemistry is required to identify minute numbers of tumor cells. With experience, pathologists identify tumors in hematoxylin and eosin (H&E) preparations in an increasing proportion of lymph nodes. Tumor cells are more frequent in the sentinel nodes of patients with primary tumors of deeper Clark level and greater Breslow thickness. Tumor cells must be discriminated from capsular nevus cells, interdigitating dendritic leukocytes, macrophages, and intranodal neural tissues.
机译:过去,高危(浓厚,深层浸润性)原发性黑色素瘤患者可通过广泛的局部切除和选择性淋巴结清扫术或仅广泛的局部切除术进行治疗,如果区域性淋巴结有临床上可检测到的转移灶,则可进行淋巴结清扫术。我们最近开发了一种更合乎逻辑的方法,称为选择性淋巴结清扫术。为了有效,这需要外科医生,病理学家和核医学医师的密切合作。淋巴结造影术前可通过淋巴显像确定引流的淋巴结盆。在手术过程中,将标记染料(异硫蓝)和放射性tech标记的白蛋白皮内注射到原发性黑色素瘤周围,然后将传入淋巴管注入到同侧区域性淋巴结的第一个淋巴结。外科医生切除蓝色且放射性最大的前哨淋巴结,病理学家严格评估这些是否存在转移性肿瘤。如果前哨淋巴结无肿瘤,则不进行进一步的淋巴结清扫术。如果存在肿瘤,则应完全切除淋巴结。我们检查了669例经选择性淋巴结清扫术治疗的患者中的1119个前哨淋巴结。我们从126例患者(17.8%)的前哨淋巴结中发现了黑色素瘤细胞。 67%的患者中有一个结点包含肿瘤,25%的患者中有2个结点是阳性,其余12%的患者有3个肿瘤结点。黑色素瘤细胞通常在周围的淋巴结窦中单个或以大小不等的组分散。在大约40%的患者中,需要免疫组织化学来鉴定微小数量的肿瘤细胞。经验丰富的病理学家可以在越来越多的淋巴结中识别苏木精和曙红(H&E)制剂中的肿瘤。原发性肿瘤克拉克水平高,Breslow厚度大的原发性肿瘤患者前哨淋巴结中的肿瘤细胞频率更高。肿瘤细胞必须与荚膜痣细胞,指状树突状白细胞,巨噬细胞和结节内神经组织区分开。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号